Provided by Tiger Fintech (Singapore) Pte. Ltd.

Context Therapeutics Inc.

0.7060
+0.05248.02%
Post-market: 0.70600.00000.00%17:46 EDT
Volume:129.91K
Turnover:88.51K
Market Cap:63.33M
PE:-0.98
High:0.7186
Open:0.6700
Low:0.6400
Close:0.6536
Loading ...
Jan 05, 2022

Major Issues Report

8-K - Current report
Dec 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 10, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 01, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Nov 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 25, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 25, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 25, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 22, 2021

Major Issues Report

8-K - Current report
Oct 20, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 18, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 18, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 29, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 29, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses